Connect with us
In phase 3 trials, Pfizer and BioNTech's vaccine showed strong immune responses against influenza A and COVID-19 but failed to meet key objectives for influenza B....
Seagen expects to generate $2.2 billion (€2.063 billion) in revenue in 2023 , which will represent a 12% year-on-year increase for the biotech company. Pfizer expects...
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
In November, Moderna already confirmed its bad omens, recording losses of $3.6 billion in the third quarter of 2023, compared to the million dollars in revenue...
BioNTech 's turnover in 2022 was €17.31 billion, which represented a decrease of 8.8%. By business segments, those from the marketing of medicines amounted to €17.2...
Pfizer closed the first quarter of 2022 with a profit of $7.86 billion, up from $4.88 billion collected between January and March 2021. The pharma developer...
Pfizer is the only company that has a pneumococcal vaccine in Spain with an indication from six weeks of age. The tender budget has been determined...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
The company Pfizer has followed in the vein of other big pharma companies. The American giant has entered the medical cannabis market in a $6.7 billion...
Gilead's peak revenue in Spain was in 2015 when the company had a turnover $1.15 billion (€978.5 million). Those figures were due to the commercialization of...